Biophama Firms Lexicon And Poniard In The Hurt Locker
Biophama companies are horrible investments at least 90% of the time because they are gambles on the IQs of small groups of scientists and the whims of the FDA. Poniard Pharmaceuticals (PARD) and Lexicon ...Read Full Story »













